Literature DB >> 1716691

Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin.

K G Gould1, H Scotney, G G Brownlee.   

Abstract

Cytotoxic T-lymphocyte (CTL) clones specific for the influenza A/PR/8/34 virus hemagglutinin (HA) were isolated by priming CBA mice with a recombinant vaccinia virus expressing the HA molecule. The epitopes recognized by two of these clones, which were CD8+, Kk restricted, and HA subtype specific, were defined by using a combination of recombinant vaccinia viruses expressing HA fragments and synthetic peptides. One epitope is in the HA1 subunit at residues 259 to 266 (numbering from the initiator methionine), amino acid sequence FEANGNLI, and the other epitope is in the HA2 subunit at residues 10 to 18 (numbering from the amino terminus of the HA2 subunit), sequence IEGGWTGMI. These two peptides are good candidates for naturally processed HA epitopes presented during influenza infection, as they are the same length (eight and nine residues) as other naturally processed viral peptides presented to CTL. A comparison of the sequences of these two new epitopes with those of the three previously published Kk-restricted T-cell epitopes showed some homology among all of the epitopes, suggesting a binding motif. In particular, an isoleucine residue at the carboxy-terminal end is present in all of the epitopes. On the basis of this homology, we predicted that the Kk-restricted epitope in influenza virus nucleoprotein, previously defined as residues 50 to 63, was contained within residues 50 to 57, sequence SDYEGRLI. This shorter peptide was found to sensitize target cells at a 200-fold lower concentration than did nucleoprotein residues 50 to 63 when tested with a CTL clone, confirming the alignment of Kk-restricted epitopes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716691      PMCID: PMC249021     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Prediction of immunodominant helper T cell antigenic sites from the primary sequence.

Authors:  H Margalit; J L Spouge; J L Cornette; K B Cease; C Delisi; J A Berzofsky
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

2.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  Fine mapping of an H-2Kk restricted cytotoxic T lymphocyte epitope in SV40 T antigen by using in-frame deletion mutants and a synthetic peptide.

Authors:  F C Rawle; K A O'Connell; R W Geib; B Roberts; L R Gooding
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

4.  Non-essential genes in the vaccinia virus HindIII K fragment: a gene related to serine protease inhibitors and a gene related to the 37K vaccinia virus major envelope antigen.

Authors:  M E Boursnell; I J Foulds; J I Campbell; M M Binns
Journal:  J Gen Virol       Date:  1988-12       Impact factor: 3.891

5.  Selection of class I MHC-restricted peptides with the strip-of-helix hydrophobicity algorithm.

Authors:  V E Reyes; L T Chin; R E Humphreys
Journal:  Mol Immunol       Date:  1988-09       Impact factor: 4.407

6.  Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.

Authors:  J W Yewdell; J R Bennink
Journal:  Science       Date:  1989-06-02       Impact factor: 47.728

7.  A sequence pattern common to T cell epitopes.

Authors:  J B Rothbard; W R Taylor
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

8.  On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes.

Authors:  T J Braciale; V L Braciale; M Winkler; I Stroynowski; L Hood; J Sambrook; M J Gething
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

9.  Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles.

Authors:  J R Bennink; J W Yewdell
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

10.  Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site.

Authors:  F Gotch; A McMichael; J Rothbard
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

View more
  14 in total

Review 1.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

2.  Effect of MHC class I diversification on influenza epitope-specific CD8+ T cell precursor frequency and subsequent effector function.

Authors:  E Bridie Day; Kim L Charlton; Nicole L La Gruta; Peter C Doherty; Stephen J Turner
Journal:  J Immunol       Date:  2011-05-02       Impact factor: 5.422

3.  Identification of the immunodominant H-2K(k)-restricted cytotoxic T-cell epitope in the Borna disease virus nucleoprotein.

Authors:  K Schamel; P Staeheli; J Hausmann
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  CD8 T cells require gamma interferon to clear borna disease virus from the brain and prevent immune system-mediated neuronal damage.

Authors:  Jürgen Hausmann; Axel Pagenstecher; Karen Baur; Kirsten Richter; Hanns-Joachim Rziha; Peter Staeheli
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice.

Authors:  Y Miyahira; A García-Sastre; D Rodriguez; J R Rodriguez; K Murata; M Tsuji; P Palese; M Esteban; F Zavala; R S Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

6.  Characterization of defectiveness in endogenous antigen presentation of novel murine cells established from methylcholanthrene-induced fibrosarcomas.

Authors:  K Kuroda; K Yamashina; N Kitatani; A Kagishima; T Hamaoka; Y Hosaka
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

7.  Antigen processing in vivo and the elicitation of primary CTL responses.

Authors:  N P Restifo; I Bacík; K R Irvine; J W Yewdell; B J McCabe; R W Anderson; L C Eisenlohr; S A Rosenberg; J R Bennink
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

8.  Transgenic mice expressing the nucleoprotein of Borna disease virus in either neurons or astrocytes: decreased susceptibility to homotypic infection and disease.

Authors:  Mathias Rauer; Jürgen Götz; Daniel Schuppli; Peter Staeheli; Jürgen Hausmann
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Virus-specific CD8+ T-cell responses in mice transgenic for a T-cell receptor beta chain selected at random.

Authors:  C Ewing; W Allan; K Daly; S Hou; G A Cole; P C Doherty; M A Blackman
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Immunodominance of major histocompatibility complex class I-restricted influenza virus epitopes can be influenced by the T-cell receptor repertoire.

Authors:  K Daly; P Nguyen; D L Woodland; M A Blackman
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.